5
Natural Biocon
NATURALBIOCONLTD NSE
Natural Biocon
ChemicalsNSE: NATURALBIOCONLTD BSE: 543207 Pesticides & Agrochemicals
Key Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsMarket Cap
₹9.07 Cr
Volatility
Moderate
P/E Ratio
-50.6
EBITDA
₹-0.03 Cr
Return on Equity
0.14%
Debt to Equity
0.01
Book Value
₹11.92
EPS
₹0.13
52W High
₹6.75
52W Low
₹3.04
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Stock is trading at 0.29 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- Promoter holding is low: 9.36%
- Company has a low return on equity of 0.23% over last 3 years.
- Company has high debtors of 736 days.
- Promoter holding has decreased over last 3 years: -11.9%
Growth Rate
Revenue Growth
-69.28% lower than
3Y
Net Income Growth
-280% lower than
3Y
Cash Flow Change
—
ROE
-88.62% lower than
3Y
ROCE
-89.62% higher than
3Y
EBITDA Margin (Avg.)
-262% lower than
3Y
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.27 | 3.24 | 2.16 | 11.37 | 0.99 | 4.74 | 1.28 | 1.35 | 1.67 | 0 | 0 | 0.88 | 0 |
| Expenses | 0.22 | 3.1 | 2.07 | 11.24 | 0.89 | 4.54 | 1.03 | 1.84 | 1.53 | 0.04 | 0.04 | 0.97 | 0.01 |
| Operating Profit | 0.05 | 0.14 | 0.09 | 0.13 | 0.1 | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| OPM % | 18.52% | 4.32% | 4.17% | 1.14% | 10.1% | 4.22% | 19.53% | -36.3% | 8.38% | — | — | -10.23% | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0.05 | 0.14 | 0.09 | 0.13 | 0.1 | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| Tax % | 0% | 0% | 22.22% | 53.85% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.05 | 0.14 | 0.08 | 0.06 | 0.1 | 0.2 | 0.25 | -0.49 | 0.14 | -0.04 | -0.04 | -0.09 | -0.01 |
| EPS in Rs | 0.04 | 0.12 | 0.07 | 0.05 | 0.09 | 0.08 | 0.1 | -0.19 | 0.05 | -0.02 | -0.02 | -0.03 | 0 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.05 | 0.15 | 1.04 | 0.45 | 0 | 0.13 | 0.48 | 1.25 | 13.53 | 8.35 | 2.55 | 0.88 |
| Expenses | 0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1 | 13.3 | 8.29 | 2.59 | 1.06 |
| Operating Profit | 0 | 0.11 | 1 | 0.11 | -0.03 | 0 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 | -0.18 |
| OPM % | 0% | 73.33% | 96.15% | 24.44% | — | 0% | 18.75% | 20% | 1.7% | 0.72% | -1.57% | -20.45% |
| Other Income | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 0 | 0.11 | 1 | 0.12 | -0.03 | 0 | 0.09 | 0.25 | 0.23 | 0.06 | -0.04 | -0.18 |
| Tax % | — | 27.27% | 30% | 41.67% | 166.67% | — | 22.22% | 28% | 30.43% | 33.33% | 0% | — |
| Net Profit | 0 | 0.08 | 0.7 | 0.07 | -0.08 | 0 | 0.07 | 0.18 | 0.15 | 0.04 | -0.04 | -0.18 |
| EPS in Rs | 0 | 0.07 | 0.62 | 0.06 | -0.07 | 0 | 0.06 | 0.16 | 0.13 | 0.02 | -0.02 | -0.07 |
| Div. Payout % | — | 0% | 0% | 81.21% | 0% | — | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 | 25.78 |
| Reserves | 0 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.09 | 4.95 |
| Borrowings | 0 | 0 | 0 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.28 | 0.38 |
| Other Liabilities | 0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 6.37 | 5.73 |
| Total Liabilities | 11.4 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.12 | 21.12 |
| Other Assets | 8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 14.11 | 12.42 |
| Total Assets | 11.4 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 38.52 | 36.84 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | 1.3 | 0.03 |
| Investing | 0 | 0 | 0 | 0 | 0 | 0 | -0.01 | 0 | 0 | -21.11 | -0.13 |
| Financing | 0 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0 | -0.02 | -0.09 | 19.67 | 0.09 |
| Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | 0 | 0.17 | 0.19 | -0.21 | -0.14 | -0.01 |
| Free Cash Flow | 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.17 | 0.21 | -0.12 | 1.3 | 0.01 |
| CFO/OP | — | 218 | 26 | -736 | -500 | — | 222 | 112 | -22 | 2,200 | -75 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 358 | 633 | — | 1,460 | 373 | 184 | 131 | 247 | 736 |
| Inventory Days | 821 | 548 | — | — | — | — | — | 382 | 4.61 | 8.4 | 0 |
| Days Payable | 0 | 0 | — | — | — | — | — | 423 | 118 | 270 | — |
| Cash Conversion Cycle | 821 | 548 | 358 | 633 | — | 1,460 | 373 | 142 | 18.07 | -14.36 | 736 |
| Working Capital Days | 7,665 | 2,239 | 572 | 681 | — | 3,818 | 357 | 134 | 49.1 | 14.86 | -132 |
| ROCE % | — | 0.97% | 8.55% | 0.97% | -0.24% | 0% | 0.73% | 2.03% | 1.85% | 0.27% | -0.13% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Natural Biocon insights
57 extracted metrics + investor summaries across FY13–FY26.
Documents
1
Board Meeting Intimation for AGM
8h - Board meeting on 18 May 2026 to approve annual report, AGM notice, and book closure dates. 8h - Board meeting on 18 May 2026 to approve annual report, AGM notice, and book closure dates.
2
Board Meeting Outcome for Audited Financial Results Along With Auditors Report For The Quarter And Year Ended March 2026
2d - Board approved FY26 audited standalone results on 9 May 2026; loss Rs4 lakh, unmodified opinion. 2d - Board approved FY26 audited standalone results on 9 May 2026; loss Rs4 lakh, unmodified opinion.
3
Audited Financial Results For The Quarter And Year Ended March 2026
2d - Board approved FY26 audited standalone results on 9 May 2026; auditors issued unmodified opinion. 2d - Board approved FY26 audited standalone results on 9 May 2026; auditors issued unmodified opinion.
4
Board Meeting Intimation for Audited Results And Audit Report
30 Apr - Board meeting to approve FY26 audited results rescheduled to 9 May 2026. 30 Apr - Board meeting to approve FY26 audited results rescheduled to 9 May 2026.
5
Board Meeting Intimation for Audited Results And Audit Report
30 Apr - Board meeting to approve FY26 audited results rescheduled to 9 May 2026. 30 Apr - Board meeting to approve FY26 audited results rescheduled to 9 May 2026.
Frequently Asked Questions about Natural Biocon
What does Natural Biocon (India) Ltd do?
Incorporated in 1992, Natural Biocon Ltd is engaged in the trading of agricultural
produce.[1]
Where is Natural Biocon (India) Ltd (543207) listed?
Natural Biocon (India) Ltd trades as NATURALBIOCONLTD on the NSE and under code 543207 on the BSE.
Which sector does Natural Biocon (India) Ltd belong to?
Natural Biocon (India) Ltd is classified under the Chemicals sector, in the Pesticides & Agrochemicals industry.
What is the market capitalisation of Natural Biocon (India) Ltd?
Natural Biocon (India) Ltd has a market capitalisation of ₹9.07 Cr, which places it in the Small Cap band.
What is the PE ratio of Natural Biocon (India) Ltd?
Natural Biocon (India) Ltd trades at a PE ratio of -50.60, on earnings per share of ₹0.13, against a book value of ₹11.92 per share.
What is the 52-week high and low of Natural Biocon (India) Ltd?
Over the last 52 weeks Natural Biocon (India) Ltd has traded between ₹3.04 and ₹6.75.
What is the Return on Equity (ROE) of Natural Biocon (India) Ltd?
Natural Biocon (India) Ltd reported a return on equity of 0.14%. Its debt-to-equity ratio is 0.01.
Company Information
Incorporated in 1992, Natural Biocon Ltd is engaged in the trading of agricultural produce.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543207.md for Natural Biocon (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.